1. Home
  2. TKNO vs SRDX Comparison

TKNO vs SRDX Comparison

Compare TKNO & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TKNO
  • SRDX
  • Stock Information
  • Founded
  • TKNO 1996
  • SRDX 1979
  • Country
  • TKNO United States
  • SRDX United States
  • Employees
  • TKNO N/A
  • SRDX N/A
  • Industry
  • TKNO Medicinal Chemicals and Botanical Products
  • SRDX Medical/Dental Instruments
  • Sector
  • TKNO Health Care
  • SRDX Health Care
  • Exchange
  • TKNO Nasdaq
  • SRDX Nasdaq
  • Market Cap
  • TKNO 356.4M
  • SRDX 415.4M
  • IPO Year
  • TKNO 2021
  • SRDX 1998
  • Fundamental
  • Price
  • TKNO $5.19
  • SRDX $28.91
  • Analyst Decision
  • TKNO Buy
  • SRDX Buy
  • Analyst Count
  • TKNO 1
  • SRDX 2
  • Target Price
  • TKNO $5.00
  • SRDX $43.00
  • AVG Volume (30 Days)
  • TKNO 232.2K
  • SRDX 62.1K
  • Earning Date
  • TKNO 08-12-2025
  • SRDX 07-30-2025
  • Dividend Yield
  • TKNO N/A
  • SRDX N/A
  • EPS Growth
  • TKNO N/A
  • SRDX N/A
  • EPS
  • TKNO N/A
  • SRDX N/A
  • Revenue
  • TKNO $38,250,000.00
  • SRDX $121,575,000.00
  • Revenue This Year
  • TKNO $8.73
  • SRDX N/A
  • Revenue Next Year
  • TKNO $16.53
  • SRDX $3.70
  • P/E Ratio
  • TKNO N/A
  • SRDX N/A
  • Revenue Growth
  • TKNO 3.79
  • SRDX N/A
  • 52 Week Low
  • TKNO $1.16
  • SRDX $26.00
  • 52 Week High
  • TKNO $10.37
  • SRDX $42.44
  • Technical
  • Relative Strength Index (RSI)
  • TKNO 33.96
  • SRDX 47.74
  • Support Level
  • TKNO $5.15
  • SRDX $28.67
  • Resistance Level
  • TKNO $5.65
  • SRDX $29.41
  • Average True Range (ATR)
  • TKNO 0.34
  • SRDX 0.66
  • MACD
  • TKNO -0.04
  • SRDX -0.07
  • Stochastic Oscillator
  • TKNO 25.68
  • SRDX 27.95

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

Share on Social Networks: